Womens Health Market 2027 by Application, Drug and Geography | The Insight Partners

Womens Health Market to 2027 - Global Analysis and Forecasts by Application ( Postmenopausal Osteoporosis, Infertility, Endometriosis, Contraceptives, Menopause, PCOS ); Drug ( Evista, Xheva, Prolia, Mirena, Zometa, Reclast/Aclasta, Minastrin 24FE, Other ), and Geography

Report Code: TIPRE00006981 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION

Women's health encompasses a wide range of specializations and focus areas, such as birth control, sexually transmitted infections (STIs), as well as gynecology, and it differs from that of men in many unique ways.

MARKET DYNAMICS

Women's Health market is anticipated to grow in the forecast period owing to an increase in the population of geriatric women, increasing adoption of an unhealthy lifestyle, and introduction of novel medicines for women can be attributed to the market growth. Moreover, favorable policies initiated by the government to improve women's health and raise awareness are likely to propel the market growth.

MARKET SCOPE

The "Global Women's Health Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Women's Health market with detailed market segmentation by application, drug and geography. The global Women's Health market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Women's Health market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global Women's Health market is segmented on the basis of application and drug. Based on application, the market is segmented as postmenopausal osteoporosis, infertility, endometriosis, contraceptives, menopause, PCOS. Based on drug, the market is segmented as Evista, Xheva, Prolia, Mirena, Zometa, Reclast/Aclasta, Minastrin 24FE, Other.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Women's Health market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Women's Health market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Women's Health market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Women's Health market in these regions.

MARKET PLAYERS


The report covers key developments in the Women's Health market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Women's Health market are anticipated to lucrative growth opportunities in the future with the rising demand for Women's Health in the global market. Below mentioned is the list of few companies engaged in the Women's Health market.

The report also includes the profiles of key Women's Health market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  • ALLERGAN
  • BAYER AG
  • MERCK AND CO., INC.
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.
  • PFIZER, INC.
  • AGILE THERAPEUTICS
  • AMGEN, INC.
  • APOTHECUS PHARMACEUTICAL CORP.
  • ASTRAZENECA
  • BLAIREX LABORATORIES, INC.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

 

TABLE OF CONTENTS

1. INTRODUCTION
 1.1. SCOPE OF THE STUDY
 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
 1.3. MARKET SEGMENTATION
 1.3.1 Women's Health Market - By Application
 1.3.2 Women's Health Market - By Drug
 1.3.3 Women's Health Market - By Region
 1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. WOMEN'S HEALTH MARKET LANDSCAPE
 4.1. OVERVIEW
 4.2. PEST ANALYSIS
 4.2.1 North America - Pest Analysis
 4.2.2 Europe - Pest Analysis
 4.2.3 Asia-Pacific - Pest Analysis
 4.2.4 Middle East and Africa - Pest Analysis
 4.2.5 South and Central America - Pest Analysis
 4.3. EXPERT OPINIONS
5. WOMEN'S HEALTH MARKET - KEY MARKET DYNAMICS
 5.1. KEY MARKET DRIVERS
 5.2. KEY MARKET RESTRAINTS
 5.3. KEY MARKET OPPORTUNITIES
 5.4. FUTURE TRENDS
 5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. WOMEN'S HEALTH MARKET - GLOBAL MARKET ANALYSIS
 6.1. WOMEN'S HEALTH - GLOBAL MARKET OVERVIEW
 6.2. WOMEN'S HEALTH - GLOBAL MARKET AND FORECAST TO 2027
 6.3. MARKET POSITIONING/MARKET SHARE
7. WOMEN'S HEALTH MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
 7.1. OVERVIEW
 7.2. APPLICATION MARKET FORECASTS AND ANALYSIS
 7.3. POSTMENOPAUSAL OSTEOPOROSIS
 7.3.1. Overview
 7.3.2. Postmenopausal Osteoporosis Market Forecast and Analysis
 7.4. INFERTILITY
 7.4.1. Overview
 7.4.2. Infertility Market Forecast and Analysis
 7.5. ENDOMETRIOSIS
 7.5.1. Overview
 7.5.2. Endometriosis Market Forecast and Analysis
 7.6. CONTRACEPTIVES
 7.6.1. Overview
 7.6.2. Contraceptives Market Forecast and Analysis
 7.7. MENOPAUSE
 7.7.1. Overview
 7.7.2. Menopause Market Forecast and Analysis
 7.8. PCOS
 7.8.1. Overview
 7.8.2. PCOS Market Forecast and Analysis
8. WOMEN'S HEALTH MARKET - REVENUE AND FORECASTS TO 2027 - DRUG
 8.1. OVERVIEW
 8.2. DRUG MARKET FORECASTS AND ANALYSIS
 8.3. EVISTA
 8.3.1. Overview
 8.3.2. Evista Market Forecast and Analysis
 8.4. XHEVA
 8.4.1. Overview
 8.4.2. Xheva Market Forecast and Analysis
 8.5. PROLIA
 8.5.1. Overview
 8.5.2. Prolia Market Forecast and Analysis
 8.6. MIRENA
 8.6.1. Overview
 8.6.2. Mirena Market Forecast and Analysis
 8.7. ZOMETA
 8.7.1. Overview
 8.7.2. Zometa Market Forecast and Analysis
 8.8. RECLAST/ACLASTA
 8.8.1. Overview
 8.8.2. Reclast/Aclasta Market Forecast and Analysis
 8.9. MINASTRIN 24FE
 8.9.1. Overview
 8.9.2. Minastrin 24FE Market Forecast and Analysis
 8.10. OTHER
 8.10.1. Overview
 8.10.2. Other Market Forecast and Analysis
9. WOMEN'S HEALTH MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
 9.1. NORTH AMERICA
 9.1.1 North America Women's Health Market Overview
 9.1.2 North America Women's Health Market Forecasts and Analysis
 9.1.3 North America Women's Health Market Forecasts and Analysis - By Application
 9.1.4 North America Women's Health Market Forecasts and Analysis - By Drug
 9.1.5 North America Women's Health Market Forecasts and Analysis - By Countries
 9.1.5.1 United States Women's Health Market
 9.1.5.1.1 United States Women's Health Market by Application
 9.1.5.1.2 United States Women's Health Market by Drug
 9.1.5.2 Canada Women's Health Market
 9.1.5.2.1 Canada Women's Health Market by Application
 9.1.5.2.2 Canada Women's Health Market by Drug
 9.1.5.3 Mexico Women's Health Market
 9.1.5.3.1 Mexico Women's Health Market by Application
 9.1.5.3.2 Mexico Women's Health Market by Drug
 9.2. EUROPE
 9.2.1 Europe Women's Health Market Overview
 9.2.2 Europe Women's Health Market Forecasts and Analysis
 9.2.3 Europe Women's Health Market Forecasts and Analysis - By Application
 9.2.4 Europe Women's Health Market Forecasts and Analysis - By Drug
 9.2.5 Europe Women's Health Market Forecasts and Analysis - By Countries
 9.2.5.1 Germany Women's Health Market
 9.2.5.1.1 Germany Women's Health Market by Application
 9.2.5.1.2 Germany Women's Health Market by Drug
 9.2.5.2 France Women's Health Market
 9.2.5.2.1 France Women's Health Market by Application
 9.2.5.2.2 France Women's Health Market by Drug
 9.2.5.3 Italy Women's Health Market
 9.2.5.3.1 Italy Women's Health Market by Application
 9.2.5.3.2 Italy Women's Health Market by Drug
 9.2.5.4 Spain Women's Health Market
 9.2.5.4.1 Spain Women's Health Market by Application
 9.2.5.4.2 Spain Women's Health Market by Drug
 9.2.5.5 United Kingdom Women's Health Market
 9.2.5.5.1 United Kingdom Women's Health Market by Application
 9.2.5.5.2 United Kingdom Women's Health Market by Drug
 9.3. ASIA-PACIFIC
 9.3.1 Asia-Pacific Women's Health Market Overview
 9.3.2 Asia-Pacific Women's Health Market Forecasts and Analysis
 9.3.3 Asia-Pacific Women's Health Market Forecasts and Analysis - By Application
 9.3.4 Asia-Pacific Women's Health Market Forecasts and Analysis - By Drug
 9.3.5 Asia-Pacific Women's Health Market Forecasts and Analysis - By Countries
 9.3.5.1 Australia Women's Health Market
 9.3.5.1.1 Australia Women's Health Market by Application
 9.3.5.1.2 Australia Women's Health Market by Drug
 9.3.5.2 China Women's Health Market
 9.3.5.2.1 China Women's Health Market by Application
 9.3.5.2.2 China Women's Health Market by Drug
 9.3.5.3 India Women's Health Market
 9.3.5.3.1 India Women's Health Market by Application
 9.3.5.3.2 India Women's Health Market by Drug
 9.3.5.4 Japan Women's Health Market
 9.3.5.4.1 Japan Women's Health Market by Application
 9.3.5.4.2 Japan Women's Health Market by Drug
 9.3.5.5 South Korea Women's Health Market
 9.3.5.5.1 South Korea Women's Health Market by Application
 9.3.5.5.2 South Korea Women's Health Market by Drug
 9.4. MIDDLE EAST AND AFRICA
 9.4.1 Middle East and Africa Women's Health Market Overview
 9.4.2 Middle East and Africa Women's Health Market Forecasts and Analysis
 9.4.3 Middle East and Africa Women's Health Market Forecasts and Analysis - By Application
 9.4.4 Middle East and Africa Women's Health Market Forecasts and Analysis - By Drug
 9.4.5 Middle East and Africa Women's Health Market Forecasts and Analysis - By Countries
 9.4.5.1 South Africa Women's Health Market
 9.4.5.1.1 South Africa Women's Health Market by Application
 9.4.5.1.2 South Africa Women's Health Market by Drug
 9.4.5.2 Saudi Arabia Women's Health Market
 9.4.5.2.1 Saudi Arabia Women's Health Market by Application
 9.4.5.2.2 Saudi Arabia Women's Health Market by Drug
 9.4.5.3 U.A.E Women's Health Market
 9.4.5.3.1 U.A.E Women's Health Market by Application
 9.4.5.3.2 U.A.E Women's Health Market by Drug
 9.5. SOUTH AND CENTRAL AMERICA
 9.5.1 South and Central America Women's Health Market Overview
 9.5.2 South and Central America Women's Health Market Forecasts and Analysis
 9.5.3 South and Central America Women's Health Market Forecasts and Analysis - By Application
 9.5.4 South and Central America Women's Health Market Forecasts and Analysis - By Drug
 9.5.5 South and Central America Women's Health Market Forecasts and Analysis - By Countries
 9.5.5.1 Brazil Women's Health Market
 9.5.5.1.1 Brazil Women's Health Market by Application
 9.5.5.1.2 Brazil Women's Health Market by Drug
 9.5.5.2 Argentina Women's Health Market
 9.5.5.2.1 Argentina Women's Health Market by Application
 9.5.5.2.2 Argentina Women's Health Market by Drug
10. INDUSTRY LANDSCAPE
 10.1. MERGERS AND ACQUISITIONS
 10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
 10.3. NEW PRODUCT LAUNCHES
 10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. WOMEN'S HEALTH MARKET, KEY COMPANY PROFILES
 11.1. ALLERGAN
 11.1.1. Key Facts
 11.1.2. Business Description
 11.1.3. Products and Services
 11.1.4. Financial Overview
 11.1.5. SWOT Analysis
 11.1.6. Key Developments
 11.2. BAYER AG
 11.2.1. Key Facts
 11.2.2. Business Description
 11.2.3. Products and Services
 11.2.4. Financial Overview
 11.2.5. SWOT Analysis
 11.2.6. Key Developments
 11.3. MERCK AND CO., INC.
 11.3.1. Key Facts
 11.3.2. Business Description
 11.3.3. Products and Services
 11.3.4. Financial Overview
 11.3.5. SWOT Analysis
 11.3.6. Key Developments
 11.4. TEVA PHARMACEUTICAL INDUSTRIES LTD.
 11.4.1. Key Facts
 11.4.2. Business Description
 11.4.3. Products and Services
 11.4.4. Financial Overview
 11.4.5. SWOT Analysis
 11.4.6. Key Developments
 11.5. PFIZER, INC.
 11.5.1. Key Facts
 11.5.2. Business Description
 11.5.3. Products and Services
 11.5.4. Financial Overview
 11.5.5. SWOT Analysis
 11.5.6. Key Developments
 11.6. AGILE THERAPEUTICS
 11.6.1. Key Facts
 11.6.2. Business Description
 11.6.3. Products and Services
 11.6.4. Financial Overview
 11.6.5. SWOT Analysis
 11.6.6. Key Developments
 11.7. AMGEN, INC.
 11.7.1. Key Facts
 11.7.2. Business Description
 11.7.3. Products and Services
 11.7.4. Financial Overview
 11.7.5. SWOT Analysis
 11.7.6. Key Developments
 11.8. APOTHECUS PHARMACEUTICAL CORP.
 11.8.1. Key Facts
 11.8.2. Business Description
 11.8.3. Products and Services
 11.8.4. Financial Overview
 11.8.5. SWOT Analysis
 11.8.6. Key Developments
 11.9. ASTRAZENECA
 11.9.1. Key Facts
 11.9.2. Business Description
 11.9.3. Products and Services
 11.9.4. Financial Overview
 11.9.5. SWOT Analysis
 11.9.6. Key Developments
 11.10. BLAIREX LABORATORIES, INC.
 11.10.1. Key Facts
 11.10.2. Business Description
 11.10.3. Products and Services
 11.10.4. Financial Overview
 11.10.5. SWOT Analysis
 11.10.6. Key Developments
12. APPENDIX
 12.1. ABOUT THE INSIGHT PARTNERS
 12.2. GLOSSARY OF TERMS

The List of Companies

1. ALLERGAN
2. BAYER AG
3. MERCK AND CO., INC.
4. TEVA PHARMACEUTICAL INDUSTRIES LTD.
5. PFIZER, INC.
6. AGILE THERAPEUTICS
7. AMGEN, INC.
8. APOTHECUS PHARMACEUTICAL CORP.
9. ASTRAZENECA
10. BLAIREX LABORATORIES, INC.